Photobiomodulation therapy to delay dystrophy progression
AssigneeMulti Radiance Medical
InventorsDouglas Johnson, Max Kanarsky, Ernesto Leal-Junior
Life of this patent
Estimating the term…
Abstract
Photobiomodulation therapy (PBMT) can be applied to a dystrophic muscle to delay dystrophy progression. A light source device can be contacted to a subject's skin proximal to a dystrophic muscle or muscle group. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the dystrophic muscle or muscle group. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the dystrophic muscle or muscle group.
Claims14
A method comprising:
- contacting a light source device to a subject's skin proximal to a dystrophic muscle or muscle group, wherein the subject has been diagnosed with muscular dystrophy;
- and
- applying a light signal through the light source device to the dystrophic muscle or muscle group,
- wherein the light source device comprises at least three light sources comprising at least a first light source operating in a super-pulsed operating mode and configured to generate a first portion of the light signal with a wavelength from 890-910 nm, a second light source operating in a pulsed operating mode or a continuous operating mode and configured to generate a second portion of the light signal with a wavelength from 600-700 nm, and a third light source operating in the pulsed operating mode or the continuous operating mode and configured to generate a third portion of the light signal with a wavelength from 810-880 nm,
- wherein the first light source comprises a super pulsed laser that creates an impulse of high intensity that emits for a billionth of a second in synchrony with a portion of the third light signal generated by the third light source.
A light source device configured to contact a subject's skin proximal to a dystrophic muscle or muscle group comprising:
- a cluster of light delivery sources comprising:
- a first light source comprising a super pulsed laser configured to generate a first portion of a light signal with a wavelength from 890-910 nm in a super-pulsed operating mode;
- a second light source configured to generate a second portion of the light signal with a wavelength from 600-700 nm in a pulsed operating mode or a continuous operating mode;
- and
- a third light source configured to generate a third portion of the light signal with a wavelength from 810-880 nm in the pulsed operating mode or the continuous operating mode, wherein the first light source creates an impulse of high intensity that emits for a billionth of a second in synchrony with a part of the third portion of the light signal generated by the third light source;
- a permanent magnet that provides a constant magnetic field having a magnetic induction from 5 mT to 1 T;
- a processing unit preprogrammed with a time for application of the light signal to the dystrophic muscle or muscle group;
- and
- a power source.
Dependencies are inferred from the claim text.